Childhood brain tumor traced to normal stem cells gone bad

August 12, 2008

Medulloblastomas are driven by mutation-altered stem/progenitor cells of the normal brain study shows

BOSTON--An aggressive childhood brain tumor known as medulloblastoma originates in normal brain "stem" cells that turn malignant when acted on by a known mutant, cancer-causing oncogene, say researchers from Dana-Farber Cancer Institute and the University of California, San Francisco (UCSF).

Reporting in the Aug. 12 issue of Cancer Cell, the scientists say they have uncovered new origins for these tumors from early stem cells as well as more mature cells. Previously, scientists had assumed the tumors might only come from a single source: more mature cells which become neurons and do not have "stem" cell properties. The findings hint at potential new treatment approaches for medulloblastoma by targeting the origins of the tumors, and further suggest that not all patients' tumors may be born from the same cells.

"We now have a better idea of where these brain tumors come from and their relationship to normal stem cells in the brain," said Keith Ligon, MD, PhD, co-senior author of the report and an investigator at the Center for Molecular Oncologic Pathology at Dana-Farber and the Brigham and Women's Hospital in Boston.

Co-senior author, David Rowitch, MD, PhD, currently a professor of pediatrics and neurosurgery at UCSF and a Howard Hughes Medical Institute investigator, commented that mouse experiments shed light on how normal stem cells -- cells with the power to create all types of cells in the brain -- can be transformed into tumors. The transformation occurs when a cell-signaling pathway known as Sonic hedgehog (named for a cartoon character) is reactivated by a chance mutation.

Sonic hedgehog plays an important role during the embryonic development of the brain, but normally shuts down when it's no longer needed. When turned on again by a mutation, the signals can trigger cell processes leading to tumors -- not just in the brain, but in other organs as well.

Medulloblastomas, usually diagnosed in children between 2 and 5 years of age, affect the brain's cerebellum region, which is involved in controlling body movements. They make up about 30 percent of childhood brain tumors, and account for 250 to 300 new cases per year.

With current treatments, approximately 60 to 70 percent of patients live at least five years, but often they are left with cognitive disabilities from surgery, chemotherapy and radiation, urgently suggesting a need for new, more-selective therapies.

"Medulloblastoma was one of the first tumors that was believed to fit the hypothesis that tumors are caused by 'cancer stem cells' that initiate malignancies and sustain them," said Ligon, who is also on faculty and an assistant professor at Harvard Medical School. "But the prevailing hypothesis -- that medulloblastomas originate from non-stem cells just did not make perfect sense with this."

The discoveries emerged from a series of experiments begun in the Rowitch Laboratory at Dana-Farber. The initial goal was to determine whether activating the Sonic hedgehog cancer pathway in multiple types of brain cells, including neural stem cells, could help pinpoint which cells brain cancers might come from. Surprisingly, the scientists generated just one tumor type, medulloblastoma, regardless of whether they activated the pathway in stem cells for other cell types called neurons and glia. This was a surprise: it had been thought that medulloblastoma arose purely from neuronal ("thinking") cells and not "glial" or supporting cells.

An intriguing question for the investigators is why these cells, known as granule neuron precursors, seem to be uniquely vulnerable to the tumor-triggering effects of the Sonic hedgehog pathway, while other brain stem and progenitor cells are not.

Explained Rowitch: "There must be susceptibility factors in the granule neuron precursor cell that predispose it to forming cancer, so we now must try to understand what it is about this cell type that makes it susceptible to forming cancer in response to Sonic hedgehog signaling. This relationship between stem cells and oncogenes suggests a new point of potential therapeutic intervention."

Dana-Farber Cancer Institute

---

---

	Tumors of the Central Nervous System, Volume 8: Astrocytoma, Medulloblastoma, Retinoblastoma, Chordoma, Craniopharyngioma, Oligodendroglioma, and Ependymoma by M.A. Hayat (Editor) With tens of thousands of new CNS tumor cases each year in the US alone, this series of publications is a valuable aid to the diagnosis and treatment of these problematic neoplasms. Now, the eighth in the set returns to the topic of brain tumors, dealing with seven distinct types: astrocytoma, medulloblastoma, retinoblastoma, chordoma, craniopharyngioma, oligodendroglioma, and ependymoma. After updating the classification of medulloblastoma the volume provides an overview of ependymoma as well as describing the delineation of prognosis based on the genetic aberrations of the latter patients. The material offers key insights into the molecular pathways involved in tumor biology, such as the role of E-cadherin gene instability, carbonic anhydrase II, urokinase plasminogen activator, and Wnt...
	The Official Parent's Sourcebook on Childhood Medulloblastoma: A Revised and Updated Directory for the Internet Age by Icon Health Publications (Author) This sourcebook has been created for parents who have decided to make education and Internet-based research an integral part of the treatment process. Although it gives information useful to doctors, caregivers and other health professionals, it also tells parents where and how to look for information covering virtually all topics related to childhood medulloblastoma, from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on childhood medulloblastoma. Following an introductory chapter, the sourcebook...
	21st Century Pediatric Cancer Sourcebook: Brain and Spinal Cord Tumors - Neuroectodermal, Medulloblastoma, Glioma, Astrocytoma, Craniopharyngioma, Craniopharyngioma, CNS Tumors, Others by Progressive Management Authoritative information and practical advice from the nation's cancer experts about childhood brain and spinal cord tumors, including neuroectodermal tumors, medulloblastomas, gliomas, astrocytomas, craniopharyngiomas, craniopharyngiomas, CNS tumors, and others. Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, this comprehensive compilation gives empowered patients, families, caregivers, nurses, and physicians the information they need to understand the diagnosis and treatment of this disease. In addition to disease-specific information, this ebook includes a glossary and information on the late effects of treatment for childhood cancer and pediatric supportive care. There are many types of childhood brain and spinal cord tumors....
	Gale Encyclopedia of Cancer: Medulloblastoma by D.O., M.P.H. Edward R. Rosick (Author) The article is excerpted from Gale Encyclopedia of Cancer The resource students and researchers will turn to for reliable, up-to-date and clearly written information, the Gale Encyclopedia of Cancer is a comprehensive survey of 120 cancers, cancer drugs, traditional and alternative treatments and diagnostic procedures. The Encyclopedia includes entries covering cancers, cancer drugs, treatments, side effects and diagnostic procedures. Entries typically include the following elements: Causes and Symptoms Definition Description Diagnosis Prevention Resources Risks Special Concerns And more An appendix provides complete contact information for cancer centers, national support groups, government agencies and research groups. Features include anatomical...
	Dysarthria following cerebellar mutism secondary to resection of a fourth ventricle medulloblastoma: a case study.(risk factors): An article from: Journal of Medical Speech - Language Pathology by Yu-Tsai Wang (Author), Ray D. Kent (Author), Joseph R. Duffy (Author), Jack E. Thomas (Author), Geoffrey V. Fredericks (Author) This digital document is an article from Journal of Medical Speech - Language Pathology, published by Thomson Gale on June 1, 2006. The length of the article is 7188 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Dysarthria following cerebellar mutism secondary to resection of a fourth ventricle medulloblastoma: a case study.(risk factors) Author: Yu-Tsai Wang Publication: Journal of Medical Speech - Language Pathology (Magazine/Journal) Date: June 1, 2006 Publisher: Thomson Gale Volume: 14 Issue: 2 Page: 109(14) Distributed by Thomson...
	Medulloblastoma: An entry from Thomson Gale's Gale Encyclopedia of Cancer, 2nd ed. by Edward, D.O., M.P.H. Rosick (Author) Students, researchers, and patients can find reliable, up-to-date and clearly written information in “The Gale Encyclopedia of Cancer,” a comprehensive survey of 120 cancers, cancer drugs, traditional and alternative treatments and diagnostic procedures.
	Medulloblastoma: Webster's Timeline History, 1949 - 2007 by Icon Group International (Author) Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Medulloblastoma," including when used in literature (e.g. all authors that might have Medulloblastoma in their name). As such, this book represents the largest compilation of timeline events associated with Medulloblastoma when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the arts,...
	21st Century Pediatric Cancer Sourcebook: Childhood Central Nervous System Embryonal Tumors - Medulloblastoma, Pineoblastoma, Pineal Parenchymal Tumors, PNET, Medulloepithelioma, Ependymoblastoma by Progressive Management Authoritative information and practical advice from the nation's cancer experts about childhood central nervous system embryonal tumors, which includes medulloblastomas, pineoblastomas, pineal parenchymal tumors, PNET, medulloepitheliomas, and ependymoblastomas. Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, this comprehensive compilation gives empowered patients, families, caregivers, nurses, and physicians the information they need to understand the diagnosis and treatment of these diseases. Conveniently organized contents include: Diagnostic Evaluation * Predictors of Outcome * Cellular Classification * Staging * Treatment Option Overview - Risk Stratification for Medulloblastoma * Surgery * Radiation Therapy * Surveillance...
	Medulloblastoma - Pipeline Review, Q1 2011 by Global Markets Direct (Author) Medulloblastoma - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Medulloblastoma - Pipeline Review, Q1 2011', provides an overview of the Medulloblastoma therapeutic pipeline. This report provides information on the therapeutic development for Medulloblastoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Medulloblastoma. 'Medulloblastoma - Pipeline Review, Q1 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by...
	Clinical case study: a 4-year-old boy with posterior fossa syndrome after resection of a medulloblastoma.(Case study): An article from: Journal of Neuroscience Nursing by Diane Schretzman Mortimer (Author) This digital document is an article from Journal of Neuroscience Nursing, published by American Association of Neuroscience Nurses on August 1, 2011. The length of the article is 3170 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Clinical case study: a 4-year-old boy with posterior fossa syndrome after resection of a medulloblastoma.(Case study) Author: Diane Schretzman Mortimer Publication: Journal of Neuroscience Nursing (Magazine/Journal) Date: August 1, 2011 Publisher: American Association of Neuroscience Nurses Volume: 43 Issue: 4 Page: 225(5) Article Type: Case...